Top Analyst Upgrades and Downgrades: Apple, Bluebird Bio, Dunkin’ Brands, Hartford Financial, ITT, Tyson Foods and Many More

June 6, 2017 by Jon C. Ogg

Stocks were indicated to open lower on Tuesday morning, a day after a 0.1% sell-off after last week’s all-time highs. The bull market is now over eight years old, and investors keep proving time after time, a trend now over five years old, that they will buy every serious stock market sell-off. Those same investors also are looking for new investing and trading ideas.

24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new investing and trading ideas for its readers. Some of these analyst reports cover stocks to buy. Other reports cover stocks to sell or to avoid.

Consensus analyst price target data are the mean of the Thomson Reuters sell-side research service. Additional color and commentary has been added on most of the daily analyst calls.

These were the top analyst upgrades, downgrades and other research calls from Tuesday, June 6, 2017.

Apple Inc. (NASDAQ: AAPL) was reiterated as Outperform with a $170 price target at Credit Suisse. The call is after the WWDC was talked up at the firm based on innovation. Just a day earlier, Apple had taken a rare analyst downgrade. Apple closed down 1% at $153.93 on Monday and was indicated down 0.3% at $153.43 on Tuesday, in a 52-week trading range of $91.50 to $156.65. It has a consensus analyst price target of $155.84.

Bluebird Bio Inc. (NASDAQ: BLUE) was raised to Outperform from Market Perform with a $108 price target (versus a $91.30 prior closing price) at BMO Capital Markets. Bluebird has a 52-week range of $36.62 to $100.40 and a consensus price target of $97.29.

Dunkin’ Brands Group Inc. (NASDAQ: DNKN) was raised to Buy from Hold with a $68 price target (versus a $58.84 close) at Argus. The 52-week range is $41.29 to $59.32, and the consensus price target is $55.86.

Hartford Financial Services Group Inc. (NYSE: HIG) was started with a Buy rating and assigned a $60 target price (versus a $49.45 close) at Deutsche Bank. It has a 52-week range of $38.92 to $50.26 and a consensus price target of $53.00.

ITT Inc. (NYSE: ITT) was downgraded to Neutral from Buy at Goldman Sachs. Shares closed down 0.6% at $39.84 on Monday, in a 52-week range of $30.06 to $44.00 and with a $46.69 consensus target price.

Tyson Foods Inc. (NYSE: TSN) was started with an Overweight rating and assigned a $70 target (versus a $58.27 close) at Barclays. Tyson has a 52-week range of $55.72 to $77.05 and a consensus price target of $68.73.

Tesla, Inc. (NASDAQ: TSLA) has a new “bullish case” up at $439 from Pacific Crest, but investors should know that this call comes with some longer-term warnings.

Other key analyst calls were seen in the following companies:

Cabot Oil & Gas Corp. (NYSE: COG) was raised to Outperform from Neutral at Macquarie.

Castlight Health Inc. (NYSE: CSLT) was started with a Buy rating and given a $4.50 price target (versus a $3.70 close) at Chardan Capital.

Catalyst Biosciences Inc. (NASDAQ: CBIO) was started with a Buy rating and assigned an $11 price target (versus a $4.17 close) at Ladenburg Thalmann. Its shares were indicated up about 9% at $4.55 on Tuesday morning.

Criteo S.A. (NASDAQ: CRTO) was reiterated as Buy with a $66 price target (versus a $48.80 close) at Jefferies, noting to buy shares on the sell-off.

Gardner Denver Holdings Inc. (NYSE: GDI) was started as Neutral with a $25 price target at Credit Suisse. It was started as Buy with a $27 target at Goldman Sachs, and started as Outperform at William Blair. Gardner Denver was started as Buy with a $28 target at UBS.

GlycoMimetics Inc. (NASDAQ: GLYC) was reiterated as Buy and the price target was raised to $16 from $9 at Jefferies.

Hormel Foods Corp. (NYSE: HRL) was started with an Overweight rating and given a $38 price target (versus a $34.16 close) at Barclays.

Medidata Solutions Inc. (NASDAQ: MDSO) was started as Buy and assigned an $85 price target (versus a $73.27 close) at Merrill Lynch.

NOW Inc. (NYSE: NOW) was started as Buy with a $21 price target (versus a $17.70 close) at Stifel.

Solaris Oilfield Infrastructure Inc. (NYSE: SOI) has seen its quiet period come to an end. Wells Fargo and Evercore ISI issued “Outperform” ratings. Several analyst calls with price targets have been seen below:

  • Credit Suisse started Solaris as Outperform with a $17 target.
  • Wunderlich started Solaris with a Buy rating and a $17 price target.
  • Piper Jaffray started it as Outperform with a $15.50 price target.
  • Goldman Sachs started it with a Buy rating and a $20.50 target price.

Veritone Inc. (NASDAQ: VERI) was started with a Buy rating and assigned an $18 price target (versus a $13.07 close) at Wunderlich.

Merrill Lynch is now more positive on eight key stocks for fundamentals and momentum. Also, Credit Suisse now sees 30% to 60% upside in four of its Focus List stocks.

Monday’s top analyst calls included Apple, Chevron, eBay, Gap, Halliburton, Juniper Networks, Yelp and many more.

Merrill Lynch issued its top picks for how to bet on the growth of Milliennials.

You can follow @Jonogg on Twitter if you want analyst calls and research notes directly on your own feed.

Essential Tips for Investing: Sponsored

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.